New Frontiers in Nanochemistry
Concepts, Theories, and Trends: Volume 3: Sustainable Nanochemistry
Herausgeber: Putz, Mihai V
New Frontiers in Nanochemistry
Concepts, Theories, and Trends: Volume 3: Sustainable Nanochemistry
Herausgeber: Putz, Mihai V
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Explains and explores 34 concepts in nanochemistry, such as anti-HIV agents, ecotoxicology, solar cells and photovoltaic phenomena, spectral-SAR, and more-alphabetically organized and accompanied by equations, figures, and brief letters in order to emphasize the potential applications of the concepts discussed.
Andere Kunden interessierten sich auch für
- New Frontiers in Nanochemistry187,99 €
- New Frontiers in Nanochemistry187,99 €
- Quantum Nanosystems224,99 €
- Nanoscience and Computational Chemistry219,99 €
- Entropy-Enthalpy Compensation165,99 €
- Clarence A. Miller / P. NeogiInterfacial Phenomena303,99 €
- Dmitrii E MakarovSingle Molecule Science182,99 €
-
-
-
Explains and explores 34 concepts in nanochemistry, such as anti-HIV agents, ecotoxicology, solar cells and photovoltaic phenomena, spectral-SAR, and more-alphabetically organized and accompanied by equations, figures, and brief letters in order to emphasize the potential applications of the concepts discussed.
Produktdetails
- Produktdetails
- Verlag: Apple Academic Press
- Seitenzahl: 500
- Erscheinungstermin: 6. Mai 2020
- Englisch
- Abmessung: 236mm x 160mm x 33mm
- Gewicht: 1157g
- ISBN-13: 9781771887793
- ISBN-10: 1771887796
- Artikelnr.: 59507311
- Verlag: Apple Academic Press
- Seitenzahl: 500
- Erscheinungstermin: 6. Mai 2020
- Englisch
- Abmessung: 236mm x 160mm x 33mm
- Gewicht: 1157g
- ISBN-13: 9781771887793
- ISBN-10: 1771887796
- Artikelnr.: 59507311
Mihai V. Putz, PhD, MBA, Dr.-Habil, is currently a Full Professor of theoretical and computational physical-chemistry at his alma mater, West University of Timisoara, Romania.
1. Anti-HIV Agents 2. Biopolymers (BIOPOLY) 3. Cancer Activity
(CA)/Anticancer Activity (ACA) 4. Cancer/Anti-Cancer Chemotherapy:
Pharmacological Management 5. Cell Cycle (CC) 6. Classification Models
Using Decision Tree, Random Forest, and Moving Average Analysis 7.
Colorants, Pigments, and Dyes (CLRNT) 8. Cuboctahedron Model of Atomic Mass
Based on a Dual Tetrahedral Coordinate System (TDCS) 9. Diabetes
Mellitus/Anti-DM Pharmacological Management 10. Drug Development 11.
Electrochemical Methods for Metal Recovery (ELMETHMETREC) 12. Free-Wilson
Model 13. HIV Infections/AIDS/Anti-HIV&AIDS: Pharmacological Management 14.
HIV-Integrase 15. Köln-Model as Toxicologically Procedure for (Some) Metals
(KMTPM) 16. Koeln-Model as Toxicologically Procedure for Oils and
Derivatives (KMTPOD) 17. Logistic Enzyme Kinetics 18. Minimal Steric
Difference (MSD) 19. Minimal Topological Difference 20. Macromolecular
Crowding (MC) 21. Polycyclic Aromatic Hydrocarbons (PAHS) 22. Pendentancy
Based Molecular Descriptors for QSAR/QSPR Studies 23. Photovoltaic System
(PVSYSTEM) 24. Protein Surface (PS) 25. Radiation (Induced) Synthesis
(RADI-SYNTH) 26. Receptor Binding 27. Smiles (SMILES) 28. Solar Cell
(SCELL) 29. Spectral-SAR 30. Stem Cells (SC) 31. Steric Taft Parameters
(STAFP) 32. Sterimol Verloop Parameters (SVEP) 33. Superaugmented Eccentric
Connectivity Indices and Their Significance in Drug Discovery Process 34.
Van Der Waals Molecular Volume
(CA)/Anticancer Activity (ACA) 4. Cancer/Anti-Cancer Chemotherapy:
Pharmacological Management 5. Cell Cycle (CC) 6. Classification Models
Using Decision Tree, Random Forest, and Moving Average Analysis 7.
Colorants, Pigments, and Dyes (CLRNT) 8. Cuboctahedron Model of Atomic Mass
Based on a Dual Tetrahedral Coordinate System (TDCS) 9. Diabetes
Mellitus/Anti-DM Pharmacological Management 10. Drug Development 11.
Electrochemical Methods for Metal Recovery (ELMETHMETREC) 12. Free-Wilson
Model 13. HIV Infections/AIDS/Anti-HIV&AIDS: Pharmacological Management 14.
HIV-Integrase 15. Köln-Model as Toxicologically Procedure for (Some) Metals
(KMTPM) 16. Koeln-Model as Toxicologically Procedure for Oils and
Derivatives (KMTPOD) 17. Logistic Enzyme Kinetics 18. Minimal Steric
Difference (MSD) 19. Minimal Topological Difference 20. Macromolecular
Crowding (MC) 21. Polycyclic Aromatic Hydrocarbons (PAHS) 22. Pendentancy
Based Molecular Descriptors for QSAR/QSPR Studies 23. Photovoltaic System
(PVSYSTEM) 24. Protein Surface (PS) 25. Radiation (Induced) Synthesis
(RADI-SYNTH) 26. Receptor Binding 27. Smiles (SMILES) 28. Solar Cell
(SCELL) 29. Spectral-SAR 30. Stem Cells (SC) 31. Steric Taft Parameters
(STAFP) 32. Sterimol Verloop Parameters (SVEP) 33. Superaugmented Eccentric
Connectivity Indices and Their Significance in Drug Discovery Process 34.
Van Der Waals Molecular Volume
1. Anti-HIV Agents 2. Biopolymers (BIOPOLY) 3. Cancer Activity
(CA)/Anticancer Activity (ACA) 4. Cancer/Anti-Cancer Chemotherapy:
Pharmacological Management 5. Cell Cycle (CC) 6. Classification Models
Using Decision Tree, Random Forest, and Moving Average Analysis 7.
Colorants, Pigments, and Dyes (CLRNT) 8. Cuboctahedron Model of Atomic Mass
Based on a Dual Tetrahedral Coordinate System (TDCS) 9. Diabetes
Mellitus/Anti-DM Pharmacological Management 10. Drug Development 11.
Electrochemical Methods for Metal Recovery (ELMETHMETREC) 12. Free-Wilson
Model 13. HIV Infections/AIDS/Anti-HIV&AIDS: Pharmacological Management 14.
HIV-Integrase 15. Köln-Model as Toxicologically Procedure for (Some) Metals
(KMTPM) 16. Koeln-Model as Toxicologically Procedure for Oils and
Derivatives (KMTPOD) 17. Logistic Enzyme Kinetics 18. Minimal Steric
Difference (MSD) 19. Minimal Topological Difference 20. Macromolecular
Crowding (MC) 21. Polycyclic Aromatic Hydrocarbons (PAHS) 22. Pendentancy
Based Molecular Descriptors for QSAR/QSPR Studies 23. Photovoltaic System
(PVSYSTEM) 24. Protein Surface (PS) 25. Radiation (Induced) Synthesis
(RADI-SYNTH) 26. Receptor Binding 27. Smiles (SMILES) 28. Solar Cell
(SCELL) 29. Spectral-SAR 30. Stem Cells (SC) 31. Steric Taft Parameters
(STAFP) 32. Sterimol Verloop Parameters (SVEP) 33. Superaugmented Eccentric
Connectivity Indices and Their Significance in Drug Discovery Process 34.
Van Der Waals Molecular Volume
(CA)/Anticancer Activity (ACA) 4. Cancer/Anti-Cancer Chemotherapy:
Pharmacological Management 5. Cell Cycle (CC) 6. Classification Models
Using Decision Tree, Random Forest, and Moving Average Analysis 7.
Colorants, Pigments, and Dyes (CLRNT) 8. Cuboctahedron Model of Atomic Mass
Based on a Dual Tetrahedral Coordinate System (TDCS) 9. Diabetes
Mellitus/Anti-DM Pharmacological Management 10. Drug Development 11.
Electrochemical Methods for Metal Recovery (ELMETHMETREC) 12. Free-Wilson
Model 13. HIV Infections/AIDS/Anti-HIV&AIDS: Pharmacological Management 14.
HIV-Integrase 15. Köln-Model as Toxicologically Procedure for (Some) Metals
(KMTPM) 16. Koeln-Model as Toxicologically Procedure for Oils and
Derivatives (KMTPOD) 17. Logistic Enzyme Kinetics 18. Minimal Steric
Difference (MSD) 19. Minimal Topological Difference 20. Macromolecular
Crowding (MC) 21. Polycyclic Aromatic Hydrocarbons (PAHS) 22. Pendentancy
Based Molecular Descriptors for QSAR/QSPR Studies 23. Photovoltaic System
(PVSYSTEM) 24. Protein Surface (PS) 25. Radiation (Induced) Synthesis
(RADI-SYNTH) 26. Receptor Binding 27. Smiles (SMILES) 28. Solar Cell
(SCELL) 29. Spectral-SAR 30. Stem Cells (SC) 31. Steric Taft Parameters
(STAFP) 32. Sterimol Verloop Parameters (SVEP) 33. Superaugmented Eccentric
Connectivity Indices and Their Significance in Drug Discovery Process 34.
Van Der Waals Molecular Volume